One of the most dreaded feelings for an investor is when the stock they just bought is overvalued, or they missed out on an undervalued opportunity by not acting fast enough.

But what if you had the insights to effectively evaluate a company like Core Laboratories N.V. before investing? Investing requires a certain perspective to avoid being overly confident in a company or worried about cyclical changes. A smart way to take the guesswork out of knowing when to buy or sell Core Laboratories N.V.’s stock is to have the right tools and resources as well as a clear monitoring process.

In this article, we go over a few key elements for understanding Core Laboratories N.V.’s stock price such as:

• Current stock price and volume
• Stock price history
• Upgrades and downgrades from analysts
• Stock price momentum as measured by its relative strength

About Core Laboratories N.V. (CLB)

Before we jump into Core Laboratories N.V.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Want to learn more about Core Laboratories N.V.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Core Laboratories N.V.. The AAII Stock Evaluator puts a company’s grades, charts, news, financials, valuation, ratios, filings and more at your fingertips.

Core Laboratories N.V.’s Stock Price as of Market Close

As of May 03, 2023, 4:00 PM CST, Core Laboratories N.V.’s stock price was $22.21.

Core Laboratories N.V. is up 4.32% from its previous closing price of $21.29.

During the last market session, Core Laboratories N.V.’s stock traded between $20.16 and $21.70. Currently, there are 46.63 million shares of Core Laboratories N.V. stock available for purchase.

Core Laboratories N.V.’s price-earnings (P/E) ratio is currently at 42.1, which is high compared to the Oil & Gas - Related Services and Equipment industry median of 16.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Core Laboratories N.V. Stock Price History

Core Laboratories N.V.’s (CLB) price is currently down 1.33% so far this month.

During the month of May, Core Laboratories N.V.’s stock price has reached a high of $22.69 and a low of $20.16.

Over the last year, Core Laboratories N.V. has hit prices as high as $31.42 and as low as $13.19. Year to date, Core Laboratories N.V.’s stock is down 0.45%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Core Laboratories N.V. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 02, 2023, there were 2 analysts who downgraded Core Laboratories N.V.’s stock and 2 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Core Laboratories N.V.’s financial health and valuation. It is possible for a stock to appear cheap based on one valuation metric but appear expensive on another. It is also possible for one valuation ratio to be associated with outperforming stocks during certain periods of time but not others.

Therefore, AAII developed a composite valuation to help resolve such issues. AAII’s Value Grade analyzes six distinct variables: price-to-sales (P/S) ratio, price-earnings (P/E) ratio, the ratio of enterprise value to earnings before interest, taxes, depreciation and amortization (EV/EBITDA), shareholder yield, price-to-book-value (P/B) ratio and price-to-free-cash-flow (P/FCF) ratio.

Core Laboratories N.V.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Core Laboratories N.V. (CLB) by visiting AAII Stock Evaluator.

Relative Price Strength of Core Laboratories N.V.

Relative price strength addresses the relationship between a stock price’s trend and the price trend of the market. This ratio is expressed as a percentage and helps investors understand a company’s momentum as well as its value. You can use relative price strength to select investments that have been outperforming the market or a specific benchmark.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. The weighted four-quarter relative price strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40%, and each of the three previous quarters are given a weighting of 20%.

As of May 02, 2023, Core Laboratories N.V. has a weighted four-quarter relative price strength of -5.17%, which translates to a Momentum Score of 50 and is considered to be Average.

Want to learn more about how Core Laboratories N.V. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Core Laboratories N.V. Stock Price: Bottom Line

As of May 3, 2023, Core Laboratories N.V.’s stock price is $22.21, which is up 4.32% from its previous closing price.

At AAII, we stress that investors should never buy or sell a stock solely based on its stock price. Past returns do not guarantee future performance. Therefore, you should consider multiple ratios, fundamentals and analytics before making a decision. Whether you decide it’s a good time to buy or sell Core Laboratories N.V.’s stock based on its stock price forecast is ultimately up to you.

It’s important to understand that stock prices are driven by a variety of factors, but ultimately the price at any given moment is due to the supply and demand in the market. Stock price overviews, like the one you just read, only give you a small snapshot of a company’s performance, value and momentum.

By becoming an A+ Investor subscriber, you will have full access to analytics, grades, stock screens, commentary and more so you can invest with confidence.